First Tracks Biotherapeutics, Inc. SEC filings TRAX
First Tracks Biotherapeutics, Inc. has 98 filings in SEC EDGAR's recent list, going back to Feb 6, 2026. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Oct 29, 2026 | — |
| EFFECT | Filing | May 12, 2026 | — |
| CORRESP | Letter to the SEC | May 8, 2026 | — |
| UPLOAD | Letter from the SEC | May 6, 2026 | — |
| DRS | Filing | May 1, 2026 | — |
| SEC STAFF ACTION | Filing | Apr 1, 2026 | — |
| CERT | Filing | Apr 1, 2026 | — |
| 10-12B/A | Filing | Mar 27, 2026 | — |
| 10-12B | Filing | Mar 3, 2026 | — |
| DRS | Filing | Feb 6, 2026 | — |
Showing 10 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- TRAX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 2091349
- Former names
- Biopharma Company, Inc. (until Feb 6, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.